OKYO Pharma Limited (OKYO)
Develops eye drop treatments for dry eyes and eye pain.
$1.64+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-47.1%
The outlook
OKYO Pharma is trading near its 52-week lows with three analysts giving it a Strong Buy rating and an average price target roughly 4× the current price. The stock sits in mixed territory relative to its moving averages, reflecting near-term uncertainty despite the bullish longer-term analyst view.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 3 analysts
Price trendMixed vs its moving averages
52-week range15% of the way from its 52-week low to high
Price targetAvg target +408% vs current price
Analyst price target
~12-month · 3 analysts$8.33average target+408.1% vs now
Now $1.64
Low $5.00High $13.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$86.1M
52-wk high
$3.35
52-wk low
$1.34
50-day avg
$1.58
200-day avg
$1.87
Trailing P/E
—